Please help us improve the quality of example sentences! Edit on Github

我的鹦鹉会学人语。My parrot can talk.

不要学人搓麻将。Chaima who will not learn.

Other words in sentence

您费尽心机学人是非分明。You tried to teach me right from wrong.

这种“市镇-学人”斗争持久达一个世纪。The "town-and-gown" fights lasted for centuries.

最后,经济学人信仰平实的语言。Lastly, The Economist believes in plain language.

新一期的经济学人简介栏目中解释了个中原因。A briefing in the new issue of The Economist helps explain why.

梳理这段历史,尤其是对其中的典型学人进行分析研究,有助于我们更好地传承学统。A retro look at this history is helpful for us to inherit the tradition.

Other words in sentence

有学人具有八个要素,阿罗汉具有十个要素。Thus the learner is endowed with eight factors, and the Arahant with ten.

此外,好像他并没对他的同辈学人有过失礼之举,是吧?Besides, it’s not likely that he’s been disrespectful to his peers, right?

期待学人指点抑或是学术争鸣,同将庄学研究推向前进。Looking forward to being taught or arguing on the theme for the further research!

八哥会学人说话,这是人人皆知的,但他怎样学人话?It is public knowledge that myna can imitate human words. But how a myna "speaks"?

论文第二部分对“新月派”学人的政治思想进行条分缕析。Part II compares and contracts the opinions inside the "Crescent School" in detail.

Other words in sentence

长期担任云南广播电视大学人文学院法学讲师。She has been a lecturer of the Yunnan Radio and Television University for ten years.

海外华裔学人在中国现代学术史上应占有一席之地。Overseas Chinese scholars should possess a position in Chinese modern academic history.

根据经济学人公布的房价与租金比指数,房价已经降至公允价格之下。Prices have dipped below fair value, according to The Economist’s price-to-rents ratio.

除去他所付出的代价,在其他经济学人的作者的文章中,依旧没有算清。The case for removing him, made among others by The Economist, has not been vindicated.

究其原因,陈衍是在以“学人之诗”思想衡评“诗人之诗”之论。In fact, Chen Yan was to comment the opinion of Poet's poem with opinion of Scholar's poem.

Other words in sentence

在经济学人的生活质量调查和名单上的国家与福利国家也包括在内。The EIU's Quality-of-life survey and a list of countries with welfare states are also included here.

韩非、法家的思想与道家之间的关系,历来受到学人的关注。Many scholars in China have been interested in the relationship between Han Fei, Legalists and Taoism.

公司的创始团队包括一群在美国生物医药行业工作多年的归国学人。Sundia Meditech is founded by a group of veterans of US pharmaceutical and bio-technological industry.